Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.99 USD | +5.56% |
|
+11.28% | +30.18% |
Jul. 15 | Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating | MT |
Jul. 01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.18% | 1.02B | |
0.00% | 8.76B | |
-20.42% | 2.72B | |
-21.53% | 2.46B | |
-24.72% | 1.93B | |
-15.72% | 1.02B | |
-18.71% | 947M | |
-3.32% | 730M | |
-32.02% | 650M | |
-36.58% | 584M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Tranche Update on Core Laboratories N.V.'s Equity Buyback Plan announced on May 22, 2017.